Mouse Anti-Human Oct 2 Monoclonal Antibody, Unconjugated, Clone PT2 from ABR-Affinity BioReagents

Rat CXCL7 (NAP-2) ELISA development Kit, DuoSet Economy Pack from R&D Systems

X-Gal from GE Healthcare, formerly Amersham Biosciences

Rat Fas, Unconjugated from R&D Systems

RABBIT (NORMAL) COMPLEMENT from AbD Serotec

Rat CXCL7 (NAP-2) ELISA development Kit, DuoSet Economy Pack from R&D Systems X-Gal from GE Healthcare, formerly Amersham Biosciences Rat Fas, Unconjugated from R&D Systems RABBIT (NORMAL) COMPLEMENT from AbD Serotec

(Date:11/4/2009)... , St. Louis, MO, November 4, 2009 Childhood obe...portions. With more than one fourth of advertising...oods and beverages and continuing questions about ...he November/December issue of the Journal of Nutr...vertising aimed at children might be a large contr...

(Date:11/4/2009)... , MADISON, N.J., Oct. 20 /PRNewswire-FirstCa...), the world,s leading provider of diagnostic test...the third quarter ended September 30, 2009, income...or $1.02 per diluted share, from $160 million, or ...2008. In 2008, third quarter results were reduced ...

(Date:11/4/2009)... , WALL, N.J., Oct. 26 /PRNewswire-FirstCall/...d: BKYI), a leader in finger-based biometric ident... identity solutions at the AABB TXPO conference be... October 25-27 2009. BIO-key will provide hands-on...entification technology in booth #424. Also, at 5 ...

[0] TV bombards children with commercials for high-fat and high-sugar foods [0] Quest Diagnostics Reports Strong Performance in Third Quarter 2009 [0] BIO-key(R) International Exhibiting at AABB TXPO

... Pretreatment with double-dose anticlotting medica...n (PCI) cuts the combined risk of heart attack and...ted at the 30th Annual Scientific Sessions of the ...ntions (SCAI), May 9?2, 2007, in Orlando, FL. , R... mg of clopidogrel before stenting, rather than th...

... Pigs carry hepatitis E virus (HEV), which they ca...ublished in Online Open Access journal BMC Veterin...o minimise the risk of human infection. The scenar...nfection rate in pigs drops. At low infection rate...s on HEV to humans at slaughter. , Kunio Satou and...

... Researchers at the University of Illinois at Chic...earch how an enzyme acts on the heart,s pacemaker ...-flight" reaction to adrenaline. , A single cell ...ing the pace of the beating heart, triggering its ...ll -- the pacemaker cell -- beats faster or slower...

Other Biology News:High-dose anticlotting drug cuts heart attack, death risk in half 2 Slowing the racing heart 2

High-dose anticlotting drug cuts heart attack, death risk in half Hepatitis E takes a piggyback Slowing the racing heart

(Date:11/6/2009)...swire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ON...day announced updated results from a Phase II stud...omas metastatic to the lung in a poster presentati...ociety Meeting held in Miami Beach, Florida, from ...tled "A Phase II Study of Intravenous REOLYSIN (Wi...

(Date:11/6/2009)...e agenda for Arrowhead’s 2010 Personalized M...ake place on February 22-24, 2010 in Philadelphia,...we will highlight key issues in forming partnershi...eriences. , Minneapolis, ...whead’s 2010 Personalized Medicine Partners...

(Date:11/5/2009).... 5 GenVec, Inc. (Nasdaq...r the third quarter ended September 30, 2009. GenV...share) for the three months ended September 30, 20...er share) in the comparable quarter of 2008. For t...net loss was $14.1 million ($0.15 per share), comp...

(Date:11/5/2009)... 5 DSM Pharmaceutical Products tod...ance with Galenix, Saint Jean D,Illac, France, whe...facturing partner for Galenix commercial products ...aborate on business development opportunities co-m... on the strength of Galenix in drug product develo...

Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2 Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3 Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2 Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3 GenVec Reports Third Quarter 2009 Financial Results 2 GenVec Reports Third Quarter 2009 Financial Results 3 GenVec Reports Third Quarter 2009 Financial Results 4 GenVec Reports Third Quarter 2009 Financial Results 5 GenVec Reports Third Quarter 2009 Financial Results 6 DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2 DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3

[0] Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting [0] Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference [0] GenVec Reports Third Quarter 2009 Financial Results [0] DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix

Products	Mouse Anti-Human Oct 2 Monoclonal Antibody, Unconjugated, Clone PT2 from ABR-Affinity BioReagents
Company	ABR-Affinity BioReagents
Item	Mouse Anti-Human Oct 2 Monoclonal Antibody, Unconjugated, Clone PT2
Price	$325.00
Description	Oct 2 Immunogen: Full length human protein. Storage: -20 C, Avoid Freeze/Thaw Cycles
Info	ABR-Affinity BioReagents ABR-Affinity BioReagents Inc. 4620 Technology Drive, Suite 600 Golden, CO 80403 USA Customer Service: +1.800.527.4535 Fax Number: +1.303.278.2424 Web Site: http://www.bioreagents.com